A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery
2021
Molecular diversity
The accumulation of massive data in the plethora of Cheminformatics databases has made the role of big data and artificial intelligence (AI) indispensable in drug design. This has necessitated the development of newer algorithms and architectures to mine these databases and fulfil the specific needs of various drug discovery processes such as virtual drug screening, de novo molecule design and discovery in this big data era. The development of deep learning neural networks and their variants
doi:10.1007/s11030-021-10256-w
pmid:34159484
pmcid:PMC8219515
fatcat:p3lsp57x6rbnxgxdu7y5dggdeu